Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy

Gastrointestinal Endoscopy

Volumn 73, Issue 3, 2011, Pages

  Stock, Christian ^a   Knudsen, Amy B ^b   Lansdorp Vogelaar, Iris ^c   Haug, Ulrike ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

AF; attributable fraction; colorectal cancer; CRC; National Health Interview Survey; NHIS; PF; prevented fraction

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CLINICAL ASSESSMENT; COLONOSCOPY; COLORECTAL CANCER; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION;

EID: 79952060257     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2010.12.005     Document Type: Article

References (57)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Espey DK, Wu X-C, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007;110:2119-52.
3. Center MM, Jemal A, Smith RA, et al. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009;59:366-78.
4. Davila RE, Rajan E, Baron TH, (Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy). ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006;63:546-57.
5. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008;149:627-37.
6. Levin B, Lieberman DA, McFarland B, et al, for the American Cancer Society Colorectal Cancer Advisory Group tUM-STF, the American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60. (Pubitemid 351830299)
7. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 2009;104:739-50.
8. Lieberman D. Colon cancer screening and surveillance controversies. Curr Opin Gastroenterol 2009;25:422-7.
9. Stock C, Haug U, Brenner H. Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends. Gastrointest Endosc 2010;71:366-81.
10. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
11. Müller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
12. Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770-5.
13. Singh H, Nugent Z, Demers AA, et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139:1128-37.
14. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
15. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
16. Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:1363-6.
17. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
18. Winawer SJ, Zauber AG, Ho MN, et al, The National Polyp Study W. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81. (Pubitemid 24015040)
19. Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32 702 veterans. Ann Intern Med 1995;123:904-10.
20. Thiis-Evensen E, Hoff GS, Sauar J, et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414-20. (Pubitemid 29232378)
21. Brenner H, Arndt V, Stürmer T, et al. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001;85:972-6. (Pubitemid 33015999)
22. Newcomb PA, Storer BE, Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5. (Pubitemid 36553509)
23. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-90.
24. Frazier AL, Colditz GA, Fuchs CS, et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-61.
25. Khandker RK, Dulski JD, Kilpatrick JB, et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 2000;16:799-810.
26. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000;133:573-84.
27. Vijan S, Hwang EW, Hofer TP, et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 2001;111:593-601. (Pubitemid 34088068)
28. Song K, Fendrick AM, Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 2004;126:1270-9. (Pubitemid 38552791)
29. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology 2005;129:1151-62. (Pubitemid 41446855)
30. Vogelaar I, van Ballegooijen M, Schrag D, et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Cancer 2006;107:1624-33.
31. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:659-69.
32. Subramanian S, Bobashev G, Morris RJ. Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiol Biomarkers Prev 2009;18:1971-8.
33. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
34. National Health Interview Survey (NHIS). Available at: http://www.cdc.gov/nchs/nhis.htm. Accessed July 5, 2010.
35. Adams P, Dey A, Vickerie J. Summary health statistics for the U.S. population: National Health Interview Survey, 2005. National Center for Health Statistics. Vital Health Stat 2007;10:1-104.
36. Surveillance, Epidemiology, and End Results (SEER) Program. Available at: www.seer.cancer.gov. SEER*Stat Database: Mortality-All COD, Aggregated With State, Total U.S. (1990-2006) 〈Katrina/Rita Population Adjustment〉, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released May 2009. Underlying mortality data provided by NCHS. Available at: www.cdc.gov/nchs. Accessed
37. Variance Estimation and Other Analytic Issues in the 1997-2005 NHIS. Available at: www.cdc.gov/nchs/data/nhis/9705var.pdf. Accessed July 5, 2010.
38. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974;99:325-32.
39. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001;10:195-216. (Pubitemid 32586161)
40. Uter W, Pfahlberg A. The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res 2001;10:231-7. (Pubitemid 32586163)
41. Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med 2008;168:1317-24. (Pubitemid 351930839)
42. Shapiro JA, Seeff LC, Thompson TD, et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008;17:1623-30.
43. Lieberman DA, Holub JL, Moravec MD, et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 2008;300:1417-22.
44. Weiss NS, McKnight B, Stevens NG. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 1992;135:817-23.
45. Karlitz JJ. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med 2009;150:816.
46. Romagnuolo J, Barkun AN, Manges AR. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med 2009;150:819.
47. Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med 2009;150:50-2.
48. Taylor C, Schultz SE, Paszat LF, et al. Prevalence of screening in patients newly diagnosed with colorectal cancer in Ontario. Can J Gastroenterol 2007;21:805-8. (Pubitemid 351255698)
49. Breen N, Wagener DK, Brown ML, et al. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13.
50. Ahmed S, Leslie A, Thaha MA, et al. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population. Br J Surg 2005;92:478-81. (Pubitemid 40523913)
51. The Northern-European Initiative on Colorectal Cancer (NordICC). ClinicalTrials. gov identifier: NCT00883792. Available at: http://www. clinicaltrials.gov/ct2/show/NCT00883792. Accessed 5 July 5, 2010.
52. Rabeneck L, Paszat LF, Hilsden RJ, et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008;135:1899-906.
53. Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006;145:880-6. (Pubitemid 351639963)
54. Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev 2000;9:229-32. (Pubitemid 30111950)
55. Hoffmeister M, Chang-Claude J, Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol 2007;166:130-6. (Pubitemid 47227287)
56. Partin MR, Grill J, Noorbaloochi S, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev 2008;17:768-76. (Pubitemid 351536404)
57. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953;9:531-41.